EchoLaser is now NMPA approved
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
EchoLaser on Corriere della Sera
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership. Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite. It is a novel technique which is...
Practical Theoretical Course at the LXY Institute in MADRID!
The theoretical - practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad!...
First Time Worldwide Use of Radio-Opaque Markers in Focal Treatment for the Prostate Cancer
EchoLaser is a multichannel laser system used for the ultrasound or fusionguided laser ablation of both benign and malignant lesions in the prostate, such as Benign Prostatic Hyperplasia and localized Prostate Cancer. EchoLaser was developed by the Italian Med-Tech...
EchoLaser: the first Choice
The echolaser phenomenon for the treatment of benign prostatic hyperplasia is spreading without limits. TPLA is increasingly being used among professionals with enormous satisfaction. Is the turn of the hospital paolo borsellino of Marsala with Dr. Emanuele Caldarera...